Polyomavirus nephropathy in kidney transplantation

Progress in Transplantation

Volumn 14, Issue 2, 2004, Pages 130-142

  Trofe, Jennifer ^a   Gordon, Jennifer ^b   Roy Chaudhury, Prabir ^a   Koralnik, Igor J ^c   Atwood, Walter J ^d   Alloway, Rita R ^a   Khalili, Kamel ^b   Woodle, E Steve ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

BIOPSY; CLASSIFICATION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MASS SCREENING; METHODOLOGY; PATHOGENICITY; PHYSIOLOGY; POLYOMA VIRUS; REOPERATION; REVIEW; RISK FACTOR; VIRUS INFECTION;

ANTIVIRAL AGENTS; BIOPSY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MASS SCREENING; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; REOPERATION; RISK FACTORS;

EID: 6944236249     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.14.2.6r72583266835340     Document Type: Article

References (140)

1. Tanphaichitr NT, Brennan DC. Infectious complications in renal transplant recipients. Adv Ren Replace Ther. 2000; 7:131-146.
2. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338:1741-1751. (Pubitemid 28268592)
3. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: Morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens. 2003;12:599-605. (Pubitemid 38186750)
4. Kazory A, Ducloux D. Renal transplantation and polyomavirus infection: Recent clinical facts and controversies. Transpl Infect Dis. June 2003;5:65-71. (Pubitemid 37221469)
5. Ashan N, Shah KV. Polyomavirus: An overview. Graft. 2002;5(suppl):S9-S18.
6. Randhawa P, Vats A, Shapiro R, Weck K, Scantlebury V. BK virus: Discovery, epidemiology and biology. Graft. 2002;5(suppl):S19-S27.
7. Shah KV. Polyomaviruses. In: Fields B, Knipe D, Howley P, eds. Field's Virology. 3rd ed. Philadelphia, Pa: Lippincott- Raven; 1996:2027-2043.
8. Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS. Simian virus 40 in human cancers. Am J Med. 2003; 114:675-684. (Pubitemid 36703237)
9. Barbanti-Brodano G, Martini F, De Mattei M, Lazzarin L, Corallini A, Tognon M. BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res. 1998;50:69-99.
10. Lee W, Langhoff E. Polyomavirus and Human Cancer. Graft. 2002;5(suppl):S73-S9.
11. Imperiale MJ. The human polyomaviruses, BKV and JCV: Molecular pathogenesis of acute disease and potential role in cancer. Virology. February 2000;267:1-7. (Pubitemid 30094147)
12. Khalili K. Human neurotropic JC virus and its association with brain tumors. Dis Markers. 2001;17:143-147. (Pubitemid 34014690)
13. Boldorini R, Pagani E, Car PG, et al. Molecular characterisation of JC virus strains detected in human brain tumours. Pathology. 2003;35:248-253. (Pubitemid 36870602)
14. Del Valle L, Gordon J, Enam S, et al. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst. 2002;94:267-273. (Pubitemid 34196320)
15. Dorries K, Loeber G, Meixensberger J. Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology. 1987;160:268-270.
16. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: Implications for human infections and disease. J Natl Cancer Inst. 1999;91:119-134. (Pubitemid 29042689)
17. Mortimer EA Jr, Lepow ML, Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med. 1981;305:1517-1518. (Pubitemid 12244208)
18. Li RM, Mannon RB, Kleiner D, et al. BK virus and SV40 coinfection in polyomavirus nephropathy. Transplantation. 2002;74:1497-1504. (Pubitemid 36014220)
19. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;1:1257-1260.
20. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1:1253-1257.
21. Major EO. Human polyomavirus. In: Knipe DM HP, Griffin DE, et al, eds. Fields Virology. 4th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2001:2175-2196.
22. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis. 1988;158:176-181.
23. Dubois V, Dutronc H, Lafon ME, et al. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol. 1997; 35:2288-2292. (Pubitemid 27349798)
24. Riley D, Toth C, Pergola P. Simultaneous manifestations of polyoma BK virus infection in two patients with kidney transplants from the same cadaver donor [abstract]. J Am Soc Nephrol. 1999;10:764.
25. Berger JR. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol. 2003;9(suppl 1):38-41. (Pubitemid 36656469)
26. Seth P, Diaz F, Major EO. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J Neurovirol. 2003;9:236-246. (Pubitemid 36656457)
27. Randhawa P, Baksh F, Aoki N, Tschirhart D, Finkelstein S. JC virus infection in allograft kidneys: Analysis by polymerase chain reaction and immunohistochemistry. Transplantation. 2001;71:1300-1303.
28. Trofe J, Cavallo T, First MR, et al. Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc. 2002;34:1788-1789.
29. Boldorini R, Omodeo-Zorini E, Nebuloni M, et al. Lytic JC virus infection in the kidneys of AIDS subjects. Mod Pathol. January 2003;16:35-42. (Pubitemid 36152684)
30. Atwood WJ, Norkin LC. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J Virol. 1989;63:4474-4477. (Pubitemid 19229453)
31. Breau WC, Atwood WJ, Norkin LC. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol. 1992;66:2037-2045.
32. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA. Gangliosides are receptors for murine polyoma virus and SV40. Embo J. 2003;22:4346-4355. (Pubitemid 37087189)
33. Liu CK, Hope AP, Atwood WJ. The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells. J Neurovirol. February 1998;4:49-58. (Pubitemid 28081578)
34. Liu CK, Wei G, Atwood WJ. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol. 1998;72:4643-4649. (Pubitemid 28215638)
35. Eash S, Tavares R, Stopa EG, Robbins SH, Brossay L, Atwood WJ. Differential distribution of the JC virus receptortype sialic acid in normal human tissues. Am J Pathol. 2004;164:419-428. (Pubitemid 38364658)
36. Seganti L, Mastromarino P, Superti F, Sinibaldi L, Orsi N. Receptors for BK virus on human erythrocytes. Acta Virol. 1981;25:177-181. (Pubitemid 11002077)
37. Sinibaldi L, Goldoni P, Pietropaolo V, Longhi C, Orsi N. Involvement of gangliosides in the interaction between BK virus and Vero cells. Arch Virol. 1990;113:291-296. (Pubitemid 20350244)
38. Sinibaldi L, Goldoni P, Pietropaolo V, Cattani L, Peluso C, Di Taranto C. Role of phospholipids in BK virus infection and haemagglutination. Microbiologica. 1992;15:337-344.
39. Imperiale MJ. The human polyomaviruses: An overview. In: Khalili K, Stoner G, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York. NY: Wiley-Liss; 2001:53-72.
40. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol. 1980;74:326-332. (Pubitemid 11179228)
41. Coleman DV, Wolfendale MR, Daniel RA, et al. A prospective study of human polyomavirus infection in pregnancy. J Infect Dis. July 1980;142:1-8. (Pubitemid 10035140)
42. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: An emerging syndrome. Transplantation. 2001;72:1587-1592. (Pubitemid 33096728)
43. Safak M, Khalili K. An overview: Human polyomavirus JC virus and its associated disorders. J Neurovirol. 2003;9(suppl 1):3-9. (Pubitemid 36656463)
44. Binet I, Nickeleit V, Hirsch H. Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant. 2000; 5:210-216.
45. Coleman DV, Mackenzie EF, Gardner SD, Poulding JM, Amer B, Russell WJ. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol. 1978;31:338-347. (Pubitemid 8315982)
46. Hirsch HH. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant. January 2002;2:25-30. (Pubitemid 36306804)
47. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BKrelated polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001;345:1250-1255. (Pubitemid 34951489)
48. Koralnik IJ, Du Pasquier RA, Kuroda MJ, et al. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol. 2002;168:499-504. (Pubitemid 34014154)
49. Du Pasquier RA, Kuroda MJ, Schmitz JE, et al. Low frequency of cytotoxic T lymphocytes against the novel HLAA* 0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol. 2003;77:11918-11926. (Pubitemid 37339845)
50. Reploeg MD, Storch GA, Clifford DB. Bk virus: A clinical review. Clin Infect Dis. 2001;33:191-202. (Pubitemid 32643334)
51. Pahari A, Rees L. BK virus-associated renal problems- clinical implications. Pediatr Nephrol. 2003;18:743-748. (Pubitemid 36949958)
52. Hirsch H, Steiger J. Polyomavirus BK. Lancet. 2003;3:611-624.
53. Drachenberg CB, Papadimitriou JC, Wali R, Cubitt CL, Ramos E. BK polyoma virus allograft nephropathy: Ultrastructural features from viral cell entry to lysis. Am J Transplant. 2003;3:1383-1392. (Pubitemid 37288083)
54. Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med. 1980;92:373-378. (Pubitemid 10154814)
55. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation. 1999;67:918-922. (Pubitemid 29169141)
56. Boubenider S, Hiesse C, Marchand S, Hafi A, Kriaa F, Charpentier B. Post-transplantation polyomavirus infections. J Nephrol. January-February 1999;12:24-29. (Pubitemid 29130700)
57. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Hum Pathol. 1999;30:970-977. (Pubitemid 29380522)
58. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A singlecenter analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation. 2003;75:1266-1270. (Pubitemid 36513032)
59. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation. 1999;68:1279-1288.
60. Hurault de Ligny B, Etienne I, Francois A, et al. Polyomavirus- induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc. 2000;32:2760-2761. (Pubitemid 32008226)
61. Lin PL, Vats AN, Green M. BK virus infection in renal transplant recipients. Pediatr Transplant. 2001;5:398-405. (Pubitemid 33095202)
62. Mayr M, Nickeleit V, Hirsch HH, Dickenmann M, Mihatsch MJ, Steiger J. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management. Am J Kidney Dis. September 2001;38:E13.
63. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant. 2003;18:1190-1196. (Pubitemid 36722523)
64. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant. 2000;15:324-332. (Pubitemid 30116466)
65. Pappo O, Demetris AJ, Raikow RB, Randhawa PS. Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance, and literature review. Mod Pathol. 1996;9:105-109. (Pubitemid 26092097)
66. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13:2145-2151. (Pubitemid 34790793)
67. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl. 2002:143-153.
68. Barri YM, Ahmad I, Ketel BL, et al. Polyoma viral infection in renal transplantation: The role of immunosuppressive therapy. Clin Transplant. 2001;15:240-246. (Pubitemid 32725406)
69. Trofe J, Gaber LW, Stratta RJ, et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis. March 2003;5:21-28. (Pubitemid 36705901)
70. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347:488-496. (Pubitemid 34879336)
71. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med. 2000;342:1361-1363. (Pubitemid 30408722)
72. Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol. 1989; 36:42-61.
73. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol. 1999;10:1080-1089. (Pubitemid 29203096)
74. Mathur VS, Olson JL, Darragh TM, Yen TS. Polyomavirusinduced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature. Am J Kidney Dis. 1997;29:754-758. (Pubitemid 27209679)
75. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int. 2003;64:665-673. (Pubitemid 36871940)
76. Randhawa PS, Vats A, Zygmunt D, et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation. 2002;74:485-488. (Pubitemid 34977676)
77. Agha I, Brennan D. BK virus and current immunosuppressive therapy. Graft. 2002;5(suppl):S65-S72. (Pubitemid 35446897)
78. Elli A, Banfi G, Fogazzi GB, Tarantino A, Ponticelli C. BK polyomavirus interstitial nephritis in a renal transplant patient with no previous acute rejection episodes. J Nephrol. 2002; 15:313-316. (Pubitemid 34830541)
79. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med. 2000; 342:1309-1315. (Pubitemid 30408715)
80. Fishman J. BK virus nephropathy-polyomavirus adding insult to injury. N Engl J Med. 2002;347:527-530. (Pubitemid 34879342)
81. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy [letters to the editor]. J Infect Dis. 2001;184:1494-1495. Author reply in J Infect Dis. 2001;184:1495-1496.
82. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67:103-109. (Pubitemid 29061146)
83. Nickeleit V, Steiger J, Mihatsch MJ. BK virus infection after kidney transplantation. Graft. 2002;5(suppl):S46-S57. (Pubitemid 35446895)
84. Hariharan A, Klassen D. BK infection after nonrenal transplantation. Graft. 2002;5(suppl):S58-S64.
85. Masuda K, Akutagawa K, Yutani C, Kishita H, Ishibashi- Ueda H, Imakita M. Persistent infection with human polyomavirus revealed by urinary cytology in a patient with heart transplantation. A case report. Acta Cytologica. 1998; 42:803-806. (Pubitemid 28274803)
86. Priftakis P, Bogdanovic G, Tyden G, Dalianis T. Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes. J Clin Microbiol. 2000;38:406-407. (Pubitemid 30043327)
87. Kristoffersen AK, Johnsen JI, Seternes OM, Rollag H, Degre M, Traavik T. The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus. Virus Res. November 1997;52:61-71. (Pubitemid 28011278)
88. Fusaro F, Murer L, Busolo F, Rigamonti W, Zanon GF, Zacchello G. CMV and BKV ureteritis: Which prognosis for the renal graft? J Nephrol. 2003;16:591-594. (Pubitemid 38120471)
89. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology. Am J Transplant. 2001;1:373-381. (Pubitemid 33681703)
90. Ding R, Medeiros M, Dadhania D, et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation. 2002;74:987-994. (Pubitemid 35191249)
91. Limaye AP, Jerome KR, Kuhr CS, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis. 2001;183:1669-1672. (Pubitemid 32466706)
92. Randhawa P, Ho A, Vats A, Shapiro R, Weck K. Quantitative measurement of BK virus load in urine and plasma of renal transplant patients: Correlation with biopsy findings [abstract 855]. Am J Transplant. 2003;3(suppl 5):371.
93. Celik B, Shapiro R, Vats A, Randhawa PS. Polyomavirus allograft nephropathy: Sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant. 2003;3:1378-1382. (Pubitemid 37288082)
94. Ahuja M, Cohen EP, Dayer AM, et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation. 2001;71:896-899. (Pubitemid 32417350)
95. Boldorini R, Zorini EO, Vigano P, Nebuloni M, Mena M, Monga G. Cytologic and biomolecular diagnosis of polyomavirus infection in urine specimens of HIV-positive patients. Acta Cytol. 2000;44:205-210. (Pubitemid 30163863)
96. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant. 2003;3:186-191. (Pubitemid 36323116)
97. Scantlebury V, Shapiro R, Randhawa P, Weck K, Vats A. Cidofovir: A method of treatment for BK virus associated transplant nephropathy. Graft. 2002;5(suppl):S82-S87. (Pubitemid 35446899)
98. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation. 2003;75:105-112. (Pubitemid 36139705)
99. Vats A. Viral load monitoring in BK virus-associated nephropathy. Nephrol News Issues. 2002;(suppl):S17-S19.
100. Trofe J, Gordon J, Roy-Chaudhury P, et al. Correlation of BK viral load monitoring and host immune response in posttransplant polyomavirus nephropathy (PVN) [abstract 852]. Am J Transplant. 2003;3(suppl 5):370.
101. Roskopf J, Fitzsimmons W, Ahsan N, Laskow D. The pharmacologic treatment of human polyomavirus infection. Graft. 2002;5(suppl):S88-S95.
102. Leventhal B, Soave R, Mouradian J, Cheigh JS. Renal dysfunction and hyperglycemia in a renal transplant recipient. Transpl Infect Dis. 1999;1:288-294.
103. Hussain S, Bresnahan BA, Cohen EP, Hariharan S. Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. Clin Transplant. February 2002;16:43-47. (Pubitemid 34555488)
104. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother. 1997;41:587-593. (Pubitemid 27098409)
105. Hou J, Major EO. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol. 1998;4:451-456. (Pubitemid 28395727)
106. De Luca A, Giancola ML, Cingolani A, et al. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis. 1999;28:624-628. (Pubitemid 29242544)
107. Hall CD, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Tri- als Group 243 Team. N Engl J Med. 1998;338:1345-1351. (Pubitemid 28216663)
108. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol. 2001;7:386-390. (Pubitemid 32894247)
109. Chapman C, Flower AJ, Durrant ST. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant. 1991;7:481-483.
110. Kawakami M, Ueda S, Maeda T, et al. Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20:485-490. (Pubitemid 27434897)
111. Seabra C, Perez-Simon JA, Sierra M, et al. Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation. Bone Marrow Transplant. 2000;26:1229-1230.
112. Vianelli N, Renga M, Azzi A, et al. Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:319-320. (Pubitemid 30103023)
113. Rand KH, Johnson KP, Rubinstein LJ, et al. Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: Use of virus-containing cells in the urine to assess response to therapy. Ann Neurol. 1977;1:458-462.
114. Barouch DH, Faquin WC, Chen Y, Koralnik IJ, Robbins GK, Davis BT. BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis. 2002;35:326-329. (Pubitemid 34800283)
115. Held TK, Biel SS, Nitsche A, et al. Treatment of BK virusassociated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant. 2000; 26:347-350. (Pubitemid 30614419)
116. Gonzalez-Fraile MI, Canizo C, Caballero D, et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis. March 2001;3:44-46. (Pubitemid 32148451)
117. Garderet L, Bittencourt H, Sebe P, et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation. 2000;70:1807-1811. (Pubitemid 32064837)
118. Marra CM, Rajicic N, Barker DE, et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. Aids. 2002;16:1791-1797.
119. Talmage DA, Listerud M. Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene. Oncogene. 1994;9:3557-3563. (Pubitemid 24359393)
120. Tarabek J, Zemla J, Bacik I. Northern blot hybridization analysis of polyoma virus-specific RNA synthesized under the block of virus replication by 5-bromo-2'-deoxyuridine. Acta Virol. 1991;35:305-312.
121. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res. 1988;9:205-218.
122. Atwood WJ. A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: Implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy. J Neurovirol. 2001;7:307-310. (Pubitemid 32894233)
123. Baum S, Ashok A, Gee G, et al. Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. J Neurovirol. 2003;9(suppl 1):32-37. (Pubitemid 36656468)
124. Atwood WJ. Cellular receptors for the polyomaviruses. In: Khalili K, Stoner G, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York, NY: Wiley-Liss; 2001:53-72.
125. Chen Y, Norkin LC. Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp Cell Res. January 1999;246:83-90. (Pubitemid 29393748)
126. Gilbert JM, Goldberg IG, Benjamin TL. Cell penetration and trafficking of polyomavirus. J Virol. 2003;77:2615-2622. (Pubitemid 36222786)
127. Anderson HA, Chen Y, Norkin LC. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell. 1996;7:1825-1834. (Pubitemid 26386733)
128. Geschwind MD, Skolasky RI, Royal WS, McArthur JC. The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J Neurovirol. 2001;7:353-357. (Pubitemid 32894241)
129. Cheeseman SH, Black PH, Rubin RH, Cantell K, Hirsch MS. Interferon and BK Papovavirus-clinical and laboratory studies. J Infect Dis. 1980;141:157-161.
130. Kerr DA, Chang CF, Gordon J, Bjornsti MA, Khalili K. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology. 1993;196:612-618.
131. Royal W 3rd, Dupont B, McGuire D, et al. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol. 2003;9:411-419. (Pubitemid 36874717)
132. Snoeck R, Andrei G, Lilja H, Fitzsimmons W, DeClercq E. Activity of malononitrilamide compounds against murine and simian polyomavirus. Abstract presented at: 5th International Conference on New Trends in Clinical and Experimental Immunosuppression; February 7-10, 2002; Geneva, Switzerland.
133. Cibrik D, O Toole J, Norman S, et al. IVIG for the treatment of BK nephropathy [abstract 850]. Am J Transplant. 2003; 3(suppl 5):370.
134. Foster P, Wright F, McLean D, et al. Leflunomide administration as an adjunctant in treatment of BK polyoma viral disease in kidney allografts [abstract 1053]. Am J Transplant. 2003;3(suppl 5):421.
135. Poduval RD, Kadambi P, Javaid B, et al. Leflunomide-a potential new therapeutic agent for BK nephropathy [abstract 144]. Am J Transplant. 2003;3(suppl 5):189.
136. Poduval RD, Meehan SM, Woodle ES, et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002;73:1166-1169. (Pubitemid 34415456)
137. Al-Jedai AH, Honaker MR, Trofe J, et al. Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: Results with kidney retransplantation. Transplantation. 2003;75:490-494. (Pubitemid 36241145)
138. Boucek P, Voska L, Saudek F. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002;74:1478. (Pubitemid 35379560)
139. Ginevri F, Pastorino N, de Santis R, et al. Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis. 2003;42:821-825. (Pubitemid 37187384)
140. Ramos E, Vincenti F, Lu WX, et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation. 2004;77:131-133. (Pubitemid 38116885)